Basic Information
Yarrow is developing ASO therapies for the treatment of severe, genetically determined central nervous system disorders. Yarrow was founded and incubated by RTW Investments in New York.
Yarrow Bioscience, Inc.
NewYork,NewYork,United States of America
unclear
May 26, 2021
--
--